ACACA_HUMAN - dbPTM
ACACA_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ACACA_HUMAN
UniProt AC Q13085
Protein Name Acetyl-CoA carboxylase 1
Gene Name ACACA
Organism Homo sapiens (Human).
Sequence Length 2346
Subcellular Localization Cytoplasm.
Protein Description Catalyzes the rate-limiting reaction in the biogenesis of long-chain fatty acids. Carries out three functions: biotin carboxyl carrier protein, biotin carboxylase and carboxyltransferase..
Protein Sequence MDEPSPLAQPLELNQHSRFIIGSVSEDNSEDEISNLVKLDLLEEKEGSLSPASVGSDTLSDLGISSLQDGLALHIRSSMSGLHLVKQGRDRKKIDSQRDFTVASPAEFVTRFGGNKVIEKVLIANNGIAAVKCMRSIRRWSYEMFRNERAIRFVVMVTPEDLKANAEYIKMADHYVPVPGGPNNNNYANVELILDIAKRIPVQAVWAGWGHASENPKLPELLLKNGIAFMGPPSQAMWALGDKIASSIVAQTAGIPTLPWSGSGLRVDWQENDFSKRILNVPQELYEKGYVKDVDDGLQAAEEVGYPVMIKASEGGGGKGIRKVNNADDFPNLFRQVQAEVPGSPIFVMRLAKQSRHLEVQILADQYGNAISLFGRDCSVQRRHQKIIEEAPATIATPAVFEHMEQCAVKLAKMVGYVSAGTVEYLYSQDGSFYFLELNPRLQVEHPCTEMVADVNLPAAQLQIAMGIPLYRIKDIRMMYGVSPWGDSPIDFEDSAHVPCPRGHVIAARITSENPDEGFKPSSGTVQELNFRSNKNVWGYFSVAAAGGLHEFADSQFGHCFSWGENREEAISNMVVALKELSIRGDFRTTVEYLIKLLETESFQMNRIDTGWLDRLIAEKVQAERPDTMLGVVCGALHVADVSLRNSVSNFLHSLERGQVLPAHTLLNTVDVELIYEGVKYVLKVTRQSPNSYVVIMNGSCVEVDVHRLSDGGLLLSYDGSSYTTYMKEEVDRYRITIGNKTCVFEKENDPSVMRSPSAGKLIQYIVEDGGHVFAGQCYAEIEVMKMVMTLTAVESGCIHYVKRPGAALDPGCVLAKMQLDNPSKVQQAELHTGSLPRIQSTALRGEKLHRVFHYVLDNLVNVMNGYCLPDPFFSSKVKDWVERLMKTLRDPSLPLLELQDIMTSVSGRIPPNVEKSIKKEMAQYASNITSVLCQFPSQQIANILDSHAATLNRKSEREVFFMNTQSIVQLVQRYRSGIRGHMKAVVMDLLRQYLRVETQFQNGHYDKCVFALREENKSDMNTVLNYIFSHAQVTKKNLLVTMLIDQLCGRDPTLTDELLNILTELTQLSKTTNAKVALRARQVLIASHLPSYELRHNQVESIFLSAIDMYGHQFCIENLQKLILSETSIFDVLPNFFYHSNQVVRMAALEVYVRRAYIAYELNSVQHRQLKDNTCVVEFQFMLPTSHPNRGNIPTLNRMSFSSNLNHYGMTHVASVSDVLLDNSFTPPCQRMGGMVSFRTFEDFVRIFDEVMGCFSDSPPQSPTFPEAGHTSLYDEDKVPRDEPIHILNVAIKTDCDIEDDRLAAMFREFTQQNKATLVDHGIRRLTFLVAQKDFRKQVNYEVDRRFHREFPKFFTFRARDKFEEDRIYRHLEPALAFQLELNRMRNFDLTAIPCANHKMHLYLGAAKVEVGTEVTDYRFFVRAIIRHSDLVTKEASFEYLQNEGERLLLEAMDELEVAFNNTNVRTDCNHIFLNFVPTVIMDPSKIEESVRSMVMRYGSRLWKLRVLQAELKINIRLTPTGKAIPIRLFLTNESGYYLDISLYKEVTDSRTAQIMFQAYGDKQGPLHGMLINTPYVTKDLLQSKRFQAQSLGTTYIYDIPEMFRQSLIKLWESMSTQAFLPSPPLPSDMLTYTELVLDDQGQLVHMNRLPGGNEIGMVAWKMTFKSPEYPEGRDIIVIGNDITYRIGSFGPQEDLLFLRASELARAEGIPRIYVSANSGARIGLAEEIRHMFHVAWVDPEDPYKGYRYLYLTPQDYKRVSALNSVHCEHVEDEGESRYKITDIIGKEEGIGPENLRGSGMIAGESSLAYNEIITISLVTCRAIGIGAYLVRLGQRTIQVENSHLILTGAGALNKVLGREVYTSNNQLGGIQIMHNNGVTHCTVCDDFEGVFTVLHWLSYMPKSVHSSVPLLNSKDPIDRIIEFVPTKTPYDPRWMLAGRPHPTQKGQWLSGFFDYGSFSEIMQPWAQTVVVGRARLGGIPVGVVAVETRTVELSIPADPANLDSEAKIIQQAGQVWFPDSAFKTYQAIKDFNREGLPLMVFANWRGFSGGMKDMYDQVLKFGAYIVDGLRECCQPVLVYIPPQAELRGGSWVVIDSSINPRHMEMYADRESRGSVLEPEGTVEIKFRRKDLVKTMRRVDPVYIHLAERLGTPELSTAERKELENKLKEREEFLIPIYHQVAVQFADLHDTPGRMQEKGVISDILDWKTSRTFFYWRLRRLLLEDLVKKKIHNANPELTDGQIQAMLRRWFVEVEGTVKAYVWDNNKDLAEWLEKQLTEEDGVHSVIEENIKCISRDYVLKQIRSLVQANPEVAMDSIIHMTQHISPTQRAEVIRILSTMDSPST
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDEPSPLA
-------CCCCCCCC
51.9019369195
4 (in isoform 4)Phosphorylation-54.2919845377
5Phosphorylation---MDEPSPLAQPLE
---CCCCCCCCCCCC
30.4223401153
5 (in isoform 4)Phosphorylation-30.42-
8 (in isoform 4)Phosphorylation-16.60-
17PhosphorylationPLELNQHSRFIIGSV
CCCCCCCCCEEEECC
21.0822199227
20 (in isoform 2)Phosphorylation-3.207907095
21 (in isoform 4)Phosphorylation-2.8622817900
22 (in isoform 2)Phosphorylation-19.7220166139
23PhosphorylationHSRFIIGSVSEDNSE
CCCEEEECCCCCCCH
16.4422167270
25PhosphorylationRFIIGSVSEDNSEDE
CEEEECCCCCCCHHH
40.7122167270
29PhosphorylationGSVSEDNSEDEISNL
ECCCCCCCHHHHHHH
59.7619664994
34PhosphorylationDNSEDEISNLVKLDL
CCCHHHHHHHHHHHH
23.2830266825
42 (in isoform 4)Phosphorylation-8.7918691976
45UbiquitinationKLDLLEEKEGSLSPA
HHHHHHHCCCCCCCC
58.98-
48PhosphorylationLLEEKEGSLSPASVG
HHHHCCCCCCCCCCC
27.1130278072
50PhosphorylationEEKEGSLSPASVGSD
HHCCCCCCCCCCCCC
21.8130278072
53PhosphorylationEGSLSPASVGSDTLS
CCCCCCCCCCCCCHH
30.3225159151
56PhosphorylationLSPASVGSDTLSDLG
CCCCCCCCCCHHHCC
25.8525159151
58PhosphorylationPASVGSDTLSDLGIS
CCCCCCCCHHHCCCC
29.8322115753
60PhosphorylationSVGSDTLSDLGISSL
CCCCCCHHHCCCCCC
32.6422115753
65PhosphorylationTLSDLGISSLQDGLA
CHHHCCCCCCCCCEE
24.1720873877
66PhosphorylationLSDLGISSLQDGLAL
HHHCCCCCCCCCEEH
28.2919664994
77PhosphorylationGLALHIRSSMSGLHL
CEEHHHHHHHCHHCH
29.7722167270
78PhosphorylationLALHIRSSMSGLHLV
EEHHHHHHHCHHCHH
13.717907095
80PhosphorylationLHIRSSMSGLHLVKQ
HHHHHHHCHHCHHHC
39.9022167270
86UbiquitinationMSGLHLVKQGRDRKK
HCHHCHHHCCCCCCC
54.09-
96PhosphorylationRDRKKIDSQRDFTVA
CCCCCCCCCCCCEEC
30.509453269
101PhosphorylationIDSQRDFTVASPAEF
CCCCCCCEECCHHHH
21.3229759185
104PhosphorylationQRDFTVASPAEFVTR
CCCCEECCHHHHHHH
21.9525850435
110PhosphorylationASPAEFVTRFGGNKV
CCHHHHHHHCCCCCE
26.1229759185
116UbiquitinationVTRFGGNKVIEKVLI
HHHCCCCCEEEEEEE
48.11-
120UbiquitinationGGNKVIEKVLIANNG
CCCCEEEEEEEECCC
31.08-
132UbiquitinationNNGIAAVKCMRSIRR
CCCCHHHHHHHHHHH
20.00-
141PhosphorylationMRSIRRWSYEMFRNE
HHHHHHHCHHHHCCC
14.9227499020
142PhosphorylationRSIRRWSYEMFRNER
HHHHHHCHHHHCCCC
12.4027499020
198 (in isoform 3)Ubiquitination-51.7121890473
210 (in isoform 3)Ubiquitination-12.9321890473
218 (in isoform 2)Ubiquitination-4.1421890473
230 (in isoform 2)Ubiquitination-6.1021890473
233 (in isoform 3)Ubiquitination-33.0921890473
234PhosphorylationIAFMGPPSQAMWALG
CCEECCHHHHHHHHH
33.4368727001
253 (in isoform 2)Ubiquitination-11.2221890473
2762-HydroxyisobutyrylationWQENDFSKRILNVPQ
CCCCCHHHHHHCCCH
43.37-
276UbiquitinationWQENDFSKRILNVPQ
CCCCCHHHHHHCCCH
43.3721906983
276 (in isoform 1)Ubiquitination-43.3721890473
286PhosphorylationLNVPQELYEKGYVKD
HCCCHHHHHCCCCCC
18.1618083107
288UbiquitinationVPQELYEKGYVKDVD
CCHHHHHCCCCCCCH
41.82-
288UbiquitinationVPQELYEKGYVKDVD
CCHHHHHCCCCCCCH
41.8221139048
288 (in isoform 1)Ubiquitination-41.8221890473
290PhosphorylationQELYEKGYVKDVDDG
HHHHHCCCCCCCHHH
18.52119453
292UbiquitinationLYEKGYVKDVDDGLQ
HHHCCCCCCCHHHHH
43.48-
311UbiquitinationVGYPVMIKASEGGGG
HCCCEEEEECCCCCC
27.9721906983
311 (in isoform 1)Ubiquitination-27.9721890473
313 (in isoform 4)Ubiquitination-31.6021890473
323MalonylationGGGKGIRKVNNADDF
CCCCCCEECCCCCCC
47.6026320211
325 (in isoform 4)Ubiquitination-40.7921890473
344PhosphorylationVQAEVPGSPIFVMRL
HHCCCCCCCEEHHHH
14.5772255733
348 (in isoform 4)Ubiquitination-1.9521890473
386UbiquitinationSVQRRHQKIIEEAPA
HHHHHHHHHHHHCCC
39.25-
410UbiquitinationHMEQCAVKLAKMVGY
HHHHHHHHHHHHHCC
24.97-
417PhosphorylationKLAKMVGYVSAGTVE
HHHHHHCCEECCEEE
4.657601369
423 (in isoform 4)Ubiquitination-4.44-
434PhosphorylationYSQDGSFYFLELNPR
EECCCCEEEEEECCC
14.677601381
442 (in isoform 3)Ubiquitination-7.6421890473
447 (in isoform 4)Ubiquitination-17.14-
462 (in isoform 2)Ubiquitination-3.2221890473
488PhosphorylationGVSPWGDSPIDFEDS
CCCCCCCCCCCCCCC
21.5919060867
520UbiquitinationENPDEGFKPSSGTVQ
CCCCCCCCCCCCCEE
55.64-
520 (in isoform 1)Ubiquitination-55.6421890473
557 (in isoform 4)Ubiquitination-9.2721890473
579UbiquitinationSNMVVALKELSIRGD
HHHHHHHHHHCCCCC
47.04-
582PhosphorylationVVALKELSIRGDFRT
HHHHHHHCCCCCHHH
16.0124719451
610PhosphorylationFQMNRIDTGWLDRLI
CCCCCCCCCHHHHHH
28.0823917254
676PhosphorylationTVDVELIYEGVKYVL
CCCHHHHHCCCEEEE
21.1846157461
734PhosphorylationMKEEVDRYRITIGNK
EHHHCCEEEEEECCE
11.2546157467
737PhosphorylationEVDRYRITIGNKTCV
HCCEEEEEECCEEEE
17.5228258704
747UbiquitinationNKTCVFEKENDPSVM
CEEEEEEECCCCCHH
50.80-
747 (in isoform 3)Ubiquitination-50.8021890473
752PhosphorylationFEKENDPSVMRSPSA
EEECCCCCHHCCCCC
31.2625159151
756PhosphorylationNDPSVMRSPSAGKLI
CCCCHHCCCCCCCEE
12.7125159151
758PhosphorylationPSVMRSPSAGKLIQY
CCHHCCCCCCCEEEE
51.4026270265
767 (in isoform 2)Ubiquitination-4.7021890473
784 (in isoform 4)Ubiquitination-5.70-
786N6-biotinyllysineYAEIEVMKMVMTLTA
EEHHHHHCHHHHHHH
33.25-
786BiotinylationYAEIEVMKMVMTLTA
EEHHHHHCHHHHHHH
33.25-
790PhosphorylationEVMKMVMTLTAVESG
HHHCHHHHHHHHHHC
15.0023663014
792PhosphorylationMKMVMTLTAVESGCI
HCHHHHHHHHHHCCE
21.3523663014
796PhosphorylationMTLTAVESGCIHYVK
HHHHHHHHCCEEEEC
32.1623663014
801PhosphorylationVESGCIHYVKRPGAA
HHHCCEEEECCCCCC
6.4323663014
813S-palmitoylationGAALDPGCVLAKMQL
CCCCCCCCEEEEEEC
2.4929575903
817AcetylationDPGCVLAKMQLDNPS
CCCCEEEEEECCCHH
24.0225953088
817UbiquitinationDPGCVLAKMQLDNPS
CCCCEEEEEECCCHH
24.02-
825UbiquitinationMQLDNPSKVQQAELH
EECCCHHHCCCHHHH
45.3721906983
825 (in isoform 1)Ubiquitination-45.3721890473
833PhosphorylationVQQAELHTGSLPRIQ
CCCHHHHCCCCCCHH
40.8823312004
835PhosphorylationQAELHTGSLPRIQST
CHHHHCCCCCCHHCC
36.0325159151
841PhosphorylationGSLPRIQSTALRGEK
CCCCCHHCCCCCCCH
17.1828857561
854 (in isoform 4)Ubiquitination-14.66-
855PhosphorylationKLHRVFHYVLDNLVN
HHHHHHHHHHHHHHH
7.407332677
862 (in isoform 4)Ubiquitination-30.4121890473
867PhosphorylationLVNVMNGYCLPDPFF
HHHHHCCCCCCCHHH
5.947332689
875PhosphorylationCLPDPFFSSKVKDWV
CCCCHHHCHHHHHHH
29.6324719451
876PhosphorylationLPDPFFSSKVKDWVE
CCCHHHCHHHHHHHH
35.9928060719
879UbiquitinationPFFSSKVKDWVERLM
HHHCHHHHHHHHHHH
50.00-
893PhosphorylationMKTLRDPSLPLLELQ
HHHHCCCCCCHHHHH
47.0863737025
907PhosphorylationQDIMTSVSGRIPPNV
HHHHHHHCCCCCCCH
23.3221712546
916UbiquitinationRIPPNVEKSIKKEMA
CCCCCHHHHHHHHHH
53.88-
977PhosphorylationQLVQRYRSGIRGHMK
HHHHHHHHCCCHHHH
29.6368718317
994PhosphorylationVMDLLRQYLRVETQF
HHHHHHHHHHHHHHC
7.0523312004
1023PhosphorylationENKSDMNTVLNYIFS
CCCHHHHHHHHHHHH
21.5222468782
1042PhosphorylationTKKNLLVTMLIDQLC
CCHHHHHHHHHHHHC
13.2620068231
1073PhosphorylationLTQLSKTTNAKVALR
HHHHCCCCCHHHHHH
36.5946157455
1076UbiquitinationLSKTTNAKVALRARQ
HCCCCCHHHHHHHHH
30.06-
1196PhosphorylationPNRGNIPTLNRMSFS
CCCCCCCCCCCEECC
32.6330576142
1201PhosphorylationIPTLNRMSFSSNLNH
CCCCCCEECCCCCCC
20.817907095
1203PhosphorylationTLNRMSFSSNLNHYG
CCCCEECCCCCCCCC
15.8323898821
1204PhosphorylationLNRMSFSSNLNHYGM
CCCEECCCCCCCCCC
43.2423898821
1209PhosphorylationFSSNLNHYGMTHVAS
CCCCCCCCCCEEEEE
13.9119276368
1212PhosphorylationNLNHYGMTHVASVSD
CCCCCCCEEEEEHHH
14.6126074081
1216PhosphorylationYGMTHVASVSDVLLD
CCCEEEEEHHHHHHC
22.5127422710
1218PhosphorylationMTHVASVSDVLLDNS
CEEEEEHHHHHHCCC
21.3626074081
1225PhosphorylationSDVLLDNSFTPPCQR
HHHHHCCCCCCCCHH
30.1126074081
1227PhosphorylationVLLDNSFTPPCQRMG
HHHCCCCCCCCHHCC
26.589453341
1238PhosphorylationQRMGGMVSFRTFEDF
HHCCCEEEEECHHHH
10.507907095
1238 (in isoform 3)Ubiquitination-10.5021890473
1257PhosphorylationDEVMGCFSDSPPQSP
HHHHCCCCCCCCCCC
41.0522167270
1258 (in isoform 2)Ubiquitination-44.9321890473
1259PhosphorylationVMGCFSDSPPQSPTF
HHCCCCCCCCCCCCC
36.9626503892
1263PhosphorylationFSDSPPQSPTFPEAG
CCCCCCCCCCCCCCC
31.5122167270
1265PhosphorylationDSPPQSPTFPEAGHT
CCCCCCCCCCCCCCC
58.0023927012
1272PhosphorylationTFPEAGHTSLYDEDK
CCCCCCCCCCCCCCC
21.3623927012
1273PhosphorylationFPEAGHTSLYDEDKV
CCCCCCCCCCCCCCC
21.1823927012
1275PhosphorylationEAGHTSLYDEDKVPR
CCCCCCCCCCCCCCC
19.6323927012
1316UbiquitinationREFTQQNKATLVDHG
HHHHHHCHHHHHHHH
38.1121906983
1316 (in isoform 1)Ubiquitination-38.1121890473
1334AcetylationLTFLVAQKDFRKQVN
HEEEEECHHHHHHCC
49.4419608861
1334MalonylationLTFLVAQKDFRKQVN
HEEEEECHHHHHHCC
49.4426320211
1334UbiquitinationLTFLVAQKDFRKQVN
HEEEEECHHHHHHCC
49.4419608861
1338UbiquitinationVAQKDFRKQVNYEVD
EECHHHHHHCCHHHH
59.60-
1342PhosphorylationDFRKQVNYEVDRRFH
HHHHHCCHHHHHHHH
20.6245553623
1353 (in isoform 4)Ubiquitination-28.0021890473
1354UbiquitinationRFHREFPKFFTFRAR
HHHHHCCCCEEEECC
59.43-
1357 (in isoform 3)Ubiquitination-18.4921890473
1370PhosphorylationKFEEDRIYRHLEPAL
CCCHHHHHHHHHHHH
7.9023917254
1371 (in isoform 4)Ubiquitination-26.08-
1375 (in isoform 4)Ubiquitination-38.64-
1377 (in isoform 2)Ubiquitination-7.7921890473
1414PhosphorylationAAKVEVGTEVTDYRF
CEEEECCCCCCCHHH
32.2420860994
1417PhosphorylationVEVGTEVTDYRFFVR
EECCCCCCCHHHHHH
22.5320860994
1435UbiquitinationRHSDLVTKEASFEYL
HCCCCCCHHHHHHHH
43.7521906983
1435 (in isoform 1)Ubiquitination-43.7521890473
1438PhosphorylationDLVTKEASFEYLQNE
CCCCHHHHHHHHHHH
21.5020068231
1441PhosphorylationTKEASFEYLQNEGER
CHHHHHHHHHHHHHH
16.1620068231
1468PhosphorylationFNNTNVRTDCNHIFL
HCCCCCCCCCCCCCC
40.3929255136
1472 (in isoform 4)Ubiquitination-20.6421890473
1480PhosphorylationIFLNFVPTVIMDPSK
CCCCCCCEEECCHHH
19.8429255136
1486PhosphorylationPTVIMDPSKIEESVR
CEEECCHHHHHHHHH
41.8429255136
1494PhosphorylationKIEESVRSMVMRYGS
HHHHHHHHHHHHHHH
17.3626074081
1499PhosphorylationVRSMVMRYGSRLWKL
HHHHHHHHHHHHHHH
11.0126074081
1501PhosphorylationSMVMRYGSRLWKLRV
HHHHHHHHHHHHHEE
18.4426074081
1524UbiquitinationIRLTPTGKAIPIRLF
EEECCCCCEEEEEEE
45.69-
1545PhosphorylationYYLDISLYKEVTDSR
EEEEEEEEEECCCCC
9.79-
1561 (in isoform 4)Ubiquitination-18.31-
1580AcetylationINTPYVTKDLLQSKR
ECCCCCCHHHHHCCC
36.0119608861
1586UbiquitinationTKDLLQSKRFQAQSL
CHHHHHCCCCCCHHC
44.25-
1608PhosphorylationIPEMFRQSLIKLWES
CHHHHHHHHHHHHHH
28.0124719451
1681 (in isoform 3)Ubiquitination-18.1821890473
1701 (in isoform 2)Ubiquitination-28.8221890473
1703PhosphorylationDLLFLRASELARAEG
HHHHHCHHHHHHHCC
27.0625002506
1710 (in isoform 3)Ubiquitination-33.9321890473
1720PhosphorylationRIYVSANSGARIGLA
EEEEECCCCCCCCHH
33.2869213931
1730 (in isoform 2)Ubiquitination-2.4921890473
1745PhosphorylationWVDPEDPYKGYRYLY
ECCCCCCCCCEEEEE
29.3925278378
1759AcetylationYLTPQDYKRVSALNS
EECHHHHHHHHHCCC
55.3919865879
1759UbiquitinationYLTPQDYKRVSALNS
EECHHHHHHHHHCCC
55.3921890473
1759 (in isoform 1)Ubiquitination-55.3921890473
1762PhosphorylationPQDYKRVSALNSVHC
HHHHHHHHHCCCEEC
30.9529116813
1769GlutathionylationSALNSVHCEHVEDEG
HHCCCEECEECCCCC
3.4722555962
1778PhosphorylationHVEDEGESRYKITDI
ECCCCCCCCEEEEEC
52.3329116813
1778 (in isoform 3)Ubiquitination-52.3321890473
1781UbiquitinationDEGESRYKITDIIGK
CCCCCCEEEEECCCC
37.71-
1788AcetylationKITDIIGKEEGIGPE
EEEECCCCCCCCCCC
42.0326051181
1788UbiquitinationKITDIIGKEEGIGPE
EEEECCCCCCCCCCC
42.0321906983
1788 (in isoform 1)Ubiquitination-42.0321890473
1796 (in isoform 4)Ubiquitination-37.8721890473
1798 (in isoform 2)Ubiquitination-49.1421890473
1818 (in isoform 4)Ubiquitination-14.24-
1825 (in isoform 4)Ubiquitination-1.8221890473
1838 (in isoform 3)Ubiquitination-14.1021890473
1844PhosphorylationRTIQVENSHLILTGA
CEEEEECCEEEEECH
13.2319060867
1849PhosphorylationENSHLILTGAGALNK
ECCEEEEECHHHHHH
20.2818187866
1851 (in isoform 3)Ubiquitination-8.5421890473
1856AcetylationTGAGALNKVLGREVY
ECHHHHHHHHCCEEE
39.4223954790
1856UbiquitinationTGAGALNKVLGREVY
ECHHHHHHHHCCEEE
39.4221906983
1856 (in isoform 1)Ubiquitination-39.4221890473
1858 (in isoform 2)Ubiquitination-5.9721890473
1871 (in isoform 2)Ubiquitination-19.7421890473
1893 (in isoform 4)Ubiquitination-6.0121890473
1908PhosphorylationYMPKSVHSSVPLLNS
CCCCCHHHCCCCCCC
30.7646157449
1916UbiquitinationSVPLLNSKDPIDRII
CCCCCCCCCCCHHHH
67.4621906983
1916 (in isoform 1)Ubiquitination-67.4621890473
1929UbiquitinationIIEFVPTKTPYDPRW
HHHCCCCCCCCCCCC
41.2421906983
1929 (in isoform 1)Ubiquitination-41.2421890473
1953 (in isoform 4)Ubiquitination-25.6821890473
1966 (in isoform 4)Ubiquitination-15.8121890473
2031AcetylationFKTYQAIKDFNREGL
HHHHHHHHHCCCCCC
60.32132707
2031UbiquitinationFKTYQAIKDFNREGL
HHHHHHHHHCCCCCC
60.32-
2047DimethylationLMVFANWRGFSGGMK
EEEEECCCCCCCCHH
35.77-
2050PhosphorylationFANWRGFSGGMKDMY
EECCCCCCCCHHHHH
36.9428258704
2068 (in isoform 4)Ubiquitination-2.88-
2081PhosphorylationCCQPVLVYIPPQAEL
HCCCEEEEECCCCCC
11.9824248375
2092PhosphorylationQAELRGGSWVVIDSS
CCCCCCCCEEEECCC
21.3727499020
2098PhosphorylationGSWVVIDSSINPRHM
CCEEEECCCCCHHHH
23.2224248375
2099PhosphorylationSWVVIDSSINPRHME
CEEEECCCCCHHHHH
23.7224248375
2108PhosphorylationNPRHMEMYADRESRG
CHHHHHEECCCHHCC
7.6419060867
2116PhosphorylationADRESRGSVLEPEGT
CCCHHCCCCCCCCCE
23.5527499020
2123PhosphorylationSVLEPEGTVEIKFRR
CCCCCCCEEEEEEEH
17.1927499020
2127AcetylationPEGTVEIKFRRKDLV
CCCEEEEEEEHHHHH
21.2220167786
2127UbiquitinationPEGTVEIKFRRKDLV
CCCEEEEEEEHHHHH
21.22-
2131 (in isoform 3)Ubiquitination-51.6721890473
2135UbiquitinationFRRKDLVKTMRRVDP
EEHHHHHHHHHHCCH
43.85-
2144PhosphorylationMRRVDPVYIHLAERL
HHHCCHHHHHHHHHH
6.496824431
2151 (in isoform 2)Ubiquitination-7.2521890473
2153PhosphorylationHLAERLGTPELSTAE
HHHHHHCCCCCCHHH
20.4121815630
2157PhosphorylationRLGTPELSTAERKEL
HHCCCCCCHHHHHHH
24.7424719451
2164 (in isoform 4)Ubiquitination-11.16-
2209UbiquitinationISDILDWKTSRTFFY
CCCCCCCCHHHHHHH
35.972190698
2209 (in isoform 1)Ubiquitination-35.9721890473
2231UbiquitinationLEDLVKKKIHNANPE
HHHHHHHHHHCCCCC
43.40-
2235 (in isoform 2)Ubiquitination-20.84-
2246 (in isoform 4)Ubiquitination-10.7021890473
2268UbiquitinationAYVWDNNKDLAEWLE
EEEEECCHHHHHHHH
61.44-
2293UbiquitinationSVIEENIKCISRDYV
HHHHHHHHEECHHHH
36.78-
2302UbiquitinationISRDYVLKQIRSLVQ
ECHHHHHHHHHHHHH
33.37-
2318PhosphorylationNPEVAMDSIIHMTQH
CHHHHHHHHHHHHCC
15.45101544951
2323PhosphorylationMDSIIHMTQHISPTQ
HHHHHHHHCCCCHHH
11.6628348404
2327PhosphorylationIHMTQHISPTQRAEV
HHHHCCCCHHHHHHH
21.5525627689
2339PhosphorylationAEVIRILSTMDSPST
HHHHHHHHCCCCCCC
21.2223186163
2340PhosphorylationEVIRILSTMDSPST-
HHHHHHHCCCCCCC-
22.8829396449
2343PhosphorylationRILSTMDSPST----
HHHHCCCCCCC----
15.2125159151
2345PhosphorylationLSTMDSPST------
HHCCCCCCC------
51.1820068231
2346PhosphorylationSTMDSPST-------
HCCCCCCC-------
46.1123186163

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
25SPhosphorylationKinaseCAMK1-FAMILY-GPS
25SPhosphorylationKinaseCAM-KI_GROUP-PhosphoELM
29SPhosphorylationKinaseCK2-FAMILY-GPS
29SPhosphorylationKinaseCK2_GROUP-PhosphoELM
78SPhosphorylationKinaseKAPCAP17612
PhosphoELM
78SPhosphorylationKinasePRKACAP17252
GPS
80SPhosphorylationKinasePRKAA1Q13131
GPS
80SPhosphorylationKinasePRKAA2P54646
GPS
80SPhosphorylationKinaseAMPK-FAMILY-GPS
80SPhosphorylationKinaseAMPK_GROUP-PhosphoELM
1201SPhosphorylationKinaseKAPCAP17612
PhosphoELM
1201SPhosphorylationKinasePRKACAP17252
GPS
1201SPhosphorylationKinaseAMPK-FAMILY-GPS
1201SPhosphorylationKinaseAMPK_GROUP-PhosphoELM
-KUbiquitinationE3 ubiquitin ligaseDET1Q7L5Y6
PMID:16794074
-KUbiquitinationE3 ubiquitin ligaseCOP1Q8NHY2
PMID:22199232
-KUbiquitinationE3 ubiquitin ligaseDET1#COP1Q7L5Y6#Q8NHY2
PMID:22199232

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
80SPhosphorylation


1263SPhosphorylation

16698035

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ACACA_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SCG1_HUMANCHGBphysical
16169070
BRCA1_HUMANBRCA1physical
16326698
BRCA1_HUMANBRCA1physical
18452305
BRCA1_HUMANBRCA1physical
16698035
ERC6L_HUMANERCC6Lphysical
22939629
PSB7_HUMANPSMB7physical
22863883
P4R3A_HUMANSMEK1physical
22863883
PSMD2_HUMANPSMD2physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
613933Acetyl-CoA carboxylase 1 deficiency (ACACAD)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00121Biotin
Regulatory Network of ACACA_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1334 AND LYS-1580, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-25 AND SER-29,AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-23; SER-29 ANDSER-80, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-25; SER-29 ANDSER-80, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-25; SER-29 ANDSER-48, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50 AND SER-488, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1844, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1042; SER-2099 ANDTYR-2108, AND MASS SPECTROMETRY.
"ACCA phosphopeptide recognition by the BRCT repeats of BRCA1.";
Ray H., Moreau K., Dizin E., Callebaut I., Venezia N.D.;
J. Mol. Biol. 359:973-982(2006).
Cited for: PHOSPHORYLATION AT SER-1263, AND MUTAGENESIS OF SER-78; SER-344;SER-432; SER-1201; SER-1263; SER-1585; SER-1952 AND SER-2211.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-25; SER-29;SER-48; SER-50; SER-53; SER-56; THR-58 AND SER-60, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29, AND MASSSPECTROMETRY.

TOP